This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cytori Therapeutics Announces Participation At The 2013 Stem Cell Meeting On The Mesa’s 3rd Annual Regen Med Partnering Forum On October 14th And 15th

Stocks in this article: CYTX

Cytori Therapeutics, Inc. (NASDAQ: CYTX) will give a company presentation at the 3rd Annual Regen Med Partnering Forum, part of the 2013 Stem Cell Meeting on the Mesa on Tuesday, October 15. In addition, Cytori’s CEO Chris Calhoun will be participating on a conference panel on Monday, October 14.

The following are specific details regarding Cytori’s presentation and panel participation at the conference:


Panel III: Financing Regenerative Medicine & Advanced Therapies

  Date:     October 14, 2013
Time: 4:00 PM PT
Location: La Jolla Ballroom CD&E, Estancia La Jolla Hotel & Spa9700 North Torrey Pines Road, La Jolla, CA, 92037

Cytori Therapeutics, Inc. Company Presentation

Date: October 15, 2013
Time: 11:45 AM PT
Location: La Jolla Ballroom CD&E, Estancia La Jolla Hotel & Spa9700 North Torrey Pines Road, La Jolla, CA, 92037

Both the presentation and the panel will be available live and will be available on the Webcasts page of Cytori’s investor relations site approximately two weeks following the conference.

The 2013 Stem Cell Meeting on the Mesa conference is being organized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine and the Sanford Consortium for Regenerative Medicine with the intention of bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science into cures.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,601.49 +244.62 1.41%
S&P 500 2,044.96 +32.07 1.59%
NASDAQ 4,718.2260 +73.9140 1.59%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs